The news this week that 23andMe, the once-popular genetic-testing company, had folded came as no great surprise. Its market value had plummeted. Its testing services were struggling. Now the big question is: what will happen to the genetic data that 23andMe collected?

Elsewhere, Myanmar has been hit by a powerful earthquake at an awful time. The country is racked by civil war. Its leaders may impose strict controls on aid so as to prevent it from reaching parts of the country that are held by rebels. The Burmese people, and those of neighbouring Thailand, also hard-hit, fear that their ordeal is far from over.